Abstract:Background and Purpose Affinity‐based selective muscarinic acetylcholine receptor (mAChR) orthosteric ligands are difficult to develop due to high sequence homology across the five receptor subtypes. Selectivity can also be achieved via the selective activation of a particular subtype or signalling pathway. Promisingly, a prior study identified compounds 6A and 7A as functionally selective and Gi biased compounds at the M2 mAChR. Here, we have investigated the activation of individual G protein subfamilies and the downstream signalling profiles of 6A and 7A at the M2 mAChR. Experimental Approach G protein activation was measured with the TRUPATH assay in M2 mAChR FlpIn CHO cells. Activity in downstream signalling pathways was determined using the cAMP CAMYEL BRET sensor and the extracellular signal‐regulated kinase 1/2 phosphorylation assay. Key Results M2 mAChR coupled to Gɑi1, GɑoA and Gɑs, but not Gɑq, in response to canonical orthosteric agonists. Compounds 6A and 7A did not elicit any G protein activation, cAMP inhibition or stimulation, or ERK 1/2 phosphorylation. Instead, a Schild analysis indicates a competitive, antagonistic interaction of compounds 6A and 7A with ACh in the Gɑi1 activation assay. Overexpression of the M2 mAChR may suggest an expression dependent activation profile of 6A and 7A. Conclusions and Implications These data validate that the M2 mAChR preferentially couples to Gɑi/o and to a lesser extent to Gɑs in response to canonical orthosteric ligands. However, this study was not able to detect Gɑi bias of compounds 6A and 7A highlighting the importance of cellular background when classifying new ligands.

An Allosteric Ligand Stabilizes Distinct Conformations in the M2 Muscarinic Acetylcholine Receptor

Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor

Positive allosteric modulation of a GPCR ternary complex

Conformational Complexity and Dynamics in a Muscarinic Receptor Revealed by NMR Spectroscopy.

Mechanism of Β 2 AR Regulation by an Intracellular Positive Allosteric Modulator

Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface

Design, synthesis and evaluation of novel 2-phenyl-3-(1 H -pyrazol-4-yl)pyridine positive allosteric modulators for the M 4 mAChR

Computational insights into diverse binding modes of the allosteric modulator and their regulation on dopamine D1 receptor

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Conformational Complexity and Dynamics in a Gpcr Revealed by Nmr Spectroscopy

Visualizing the M2 muscarinic acetylcholine receptor activation regulated by aromatic ring dynamics

Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization

Detection and Quantification of Allosteric Modulation of Endogenous M4 Muscarinic Acetylcholine Receptor Using Impedance-Based Label-Free Technology in a Neuronal Cell Line

Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1

Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor

Importance of receptor expression in the classification of novel ligands at the M2 muscarinic acetylcholine receptor

Discovery of 2-Methyl-5-(1 H -pyrazol-4-yl)pyridines and Related Heterocycles as Promising M 4 mAChR Positive Allosteric Modulators for the Treatment of Neurocognitive Disorders

Structural Basis of Orientated Asymmetry in a Mglu Heterodimer

Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator

Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.